Glenview Trust Co’s Johnson & Johnson Position
Does Glenview Trust Co own Johnson & Johnson (JNJ)? Yes — 152.6K shares worth $37M (+0.59% of its 13F portfolio) as of Q1 2026, up from 151.8K shares the prior filed quarter.
Position Value
$37M
Q1 2026
Shares
152.6K
% of Portfolio
+0.59%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 152.6K | $37M | +0.59% |
| Q4 2025 | 151.8K | $31M | +0.48% |
| Q3 2025 | 150.2K | $28M | +0.44% |
| Q2 2025 | 150.8K | $23M | +0.40% |
| Q1 2025 | 150.7K | $25M | +0.49% |
| Q4 2024 | 153.4K | $22M | +0.42% |
| Q3 2024 | 157.4K | $26M | +0.49% |
| Q2 2024 | 157.1K | $23M | +0.46% |
| Q1 2024 | 157.8K | $25M | +0.54% |
| Q4 2023 | 159.7K | $25M | +0.61% |
| Q3 2023 | 158.7K | $25M | +0.68% |
| Q2 2023 | 157.8K | $26M | +0.71% |
| Q1 2023 | 155.9K | $24M | +0.72% |
| Q4 2022 | 155.4K | $27M | +0.91% |
| Q3 2022 | 150.9K | $25M | +0.93% |
| Q2 2022 | 152.5K | $27M | +0.99% |
| Q1 2022 | 151.5K | $27M | +0.87% |
| Q4 2021 | 151.5K | $26M | +0.86% |
| Q3 2021 | 142.6K | $23M | +0.89% |
| Q2 2021 | 141.6K | $23M | +0.90% |
| Q1 2021 | 139.5K | $23M | +0.99% |
| Q4 2020 | 147.9K | $23M | +1.08% |
| Q3 2020 | 148.9K | $22M | +1.15% |
| Q2 2020 | 149.1K | $21M | +1.19% |
| Q1 2020 | 149.7K | $20M | +1.36% |
| Q4 2019 | 151.1K | $22M | +1.23% |
| Q3 2019 | 154.8K | $20M | +1.21% |
| Q2 2019 | 157.0K | $22M | +1.36% |
| Q1 2019 | 158.5K | $22M | +1.42% |
| Q4 2018 | 161.7K | $21M | +1.54% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Glenview Trust Co’s full portfolio or all institutional holders of JNJ.